English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe Howard Hughes Medical Institute (HHMI) has selected Ian Maze, PhD, Associate Professor of Neuroscience, and Pharmacological Sciences, at the Icahn School of Medicine at Mount Sinai, as an HHMI Investigator.
Tag: Icahn School of Medicine at Mount Sinai
Mount Sinai Boards of Trustees Announce Updated Leadership Structure
The Mount Sinai Boards of Trustees today announced leadership updates that will position the Mount Sinai Health System for future challenges and opportunities.
Mount Sinai Researchers Use Wearable Devices to Identify Psychological Effects of Pandemic
Study links changes in heart rate variability with degree of resilience, as part of larger effort to understand and mitigate the effects of COVID-19 on health care workers
Mount Sinai’s Center for Psychedelic Psychotherapy and Trauma Research Receives $5 Million Grant From The Bob & Renee Parsons Foundation
Funds will support cutting-edge MDMA-assisted therapy for PTSD
Mount Sinai Health System Launches Comprehensive Mobile App for Patients
New features include upload for COVID-19 vaccination proof and hospital navigation
Mount Sinai Cardiologist Leads Effort to Outline Guidance for Management of Heart Failure Patients During COVID-19 Pandemic
New scientific statement aims to establish more streamlined care to improve outcomes in this high-risk group
Edoxaban May Be Effective Treatment for Atrial Fibrillation After Transcatheter Aortic Valve Replacement
Mount Sinai study is first to compare this anticoagulant with the standard of care in large randomized clinical trial
Mount Sinai Receives $2.9 Million to Study First-of-its-kind Brain Implant for Restoring Function in Paralyzed Patients
Department of Rehabilitation and Human Performance will lead Mount Sinai in national clinical trial
Mount Sinai Queens Earns Prestigious Thrombectomy-Capable Stroke Certification From Joint Commission
The hospital achieved this recognition by meeting rigorous standards for performing endovascular thrombectomy and demonstrating continuous compliance with its performance standards.
Mount Sinai Study Identifies Significant Inequalities Among Low-Risk Births, Finds Higher Rates of Unexpected Complications for Black and Hispanic Infants
Hospital quality of care during delivery is a major factor for racial and ethnic disparities among low-risk newborns
Mount Sinai Announces Landmark Gift from James S. and Merryl H. Tisch to Transform Cancer Care in New York
The Mount Sinai Health System announced today a game-changing $60 million gift from James S. and Merryl H. Tisch to establish the Mount Sinai Tisch Cancer Center.
First of its kind study using multi-omics approach identifies large list of candidate genes associated with alcohol use disorder
New York, NY (Aug 20, 2021) – Researchers from the Icahn School of Medicine at Mount Sinai have published the first study of its kind in the field of addiction genetics using a multi-omics approach to provide a large list…
Mount Sinai Heart Earns Two Prestigious Recognitions for Heart Failure and Catherization Lab
Awards highlight highest level of quality of care
Mount Sinai Mandates COVID-19 Vaccination for All Faculty and Staff
Mount Sinai Health System today announced that all faculty and staff will be required to get the first shot of the vaccine by September 13.
Mount Sinai Mandates COVID-19 Vaccination for All Faculty and Staff
Mount Sinai Health System today announced that all faculty and staff will be required to get the first shot of the vaccine by September 13.
Mount Sinai Receives NCI Grant to Study Anal Cancer Screening in High-Risk Women
The Icahn School of Medicine at Mount Sinai has been awarded a grant of more than $4 million by the National Cancer Institute for a large-scale study to evaluate anal cancer screening in high-risk women who have been previously diagnosed with human papillomavirus (HPV) infection.
Mount Sinai Health System Launches Bold $2 Billion Capital Campaign
Expanding upon its nearly 170-year history of innovation and discovery, the Mount Sinai Health System has launched a bold capital campaign to raise $2 billion by 2025 that will power the organization into a forward-looking era of advanced patient care, research, and education.
Mount Sinai Mobile Interventional Stroke Team Travels to Patients, Resulting in Faster Treatment and Better Outcomes
Study finds stroke patients are nearly twice as likely to be functionally independent if treated by a specialized team that travels to them to perform surgical clot removal
Study Shows Visual Evoked Potential Is a Promising Tool for Translational Research Into Phelan-McDermid Syndrome and Autism Spectrum Disorders
Researchers at the Seaver Autism Center for Research and Treatment at Mount Sinai have identified specific transient visual evoked potential waveform abnormalities in individuals with Phelan-McDermid syndrome (PMS), proving the method to be an effective, noninvasive technique to gather objective data from a range of individuals, including those who are profoundly affected.
Mount Sinai’s J Mocco, MD, to Lead the Society of NeuroInterventional Surgery
J Mocco, MD, MS, Senior Vice Chair, Director of the Cerebrovascular Center, and Co-Director of the Neuroendovascular Surgery Fellowship Program in the Department of Neurosurgery at Mount Sinai, has been named president-elect of the Society of NeuroInterventional Surgery (SNIS), a scientific and educational association dedicated to advancing the specialty of neurointerventional surgery, effective July 29, 2021.
The Mount Sinai Hospital’s Department of Geriatrics Remains No. 1 in U.S. News & World Report Specialty Rankings for Second Year
The Mount Sinai Hospital’s Department of Geriatrics was ranked No. 1 in the nation by U.S. News & World Report for the second consecutive year. The Mount Sinai Hospital was also listed on the “Honor Roll” of the nation’s top 20 hospitals for the sixth year in a row.
Mount Sinai scientists discover early signs of frontotemporal dementia in personalized cerebral organoids
Frontotemporal dementias are a group of fatal and debilitating brain disorders for which there are no cures. In an article published July 26 in Cell, Mount Sinai researchers describe how they were able to recreate much of the damage seen in a widely studied form of the disease by growing special types of cerebral organoids in petri dishes.
The Steven & Alexandra Cohen Foundation Grants More than $2.1 Million to Support a Psychedelics Research Study at Mount Sinai
The Center for Psychedelic Psychotherapy and Trauma Research in the Department of Psychiatry at Mount Sinai today announced a $2.1 million charitable contribution by the Steven & Alexandra Cohen Foundation.
Mount Sinai’s Kalmon D. Post, MD, to Lead The Pituitary Society
Kalmon D. Post, MD, Surgical Co-Director of the Pituitary Care and Research Center, and Chair Emeritus of the Department of Neurosurgery, the Faculty Practice Associates, and The Medical Board at Mount Sinai, has been named president-elect of The Pituitary Society, effective Thursday, July 1
Mount Sinai Recruits Internationally Recognized Cardiovascular Immunology Researcher
Filip Swirski, PhD, named Director of Mount Sinai’s new Cardiovascular Research Institute
Mount Sinai Named Official Medical Service Provider for USA Fencing Team
Department of Rehabilitation and Human Performance prepares athletes for Tokyo Olympic Games
Mount Sinai Research Reveals How the Ebola Virus Manages to Evade the Body’s Immune Defenses
Mount Sinai researchers have uncovered the complex cellular mechanisms of Ebola virus, which could help explain its severe toll on humans and identify potential pathways to treatment and prevention. In a study published in mBio, the team reported how a protein of the Ebola virus, VP24, interacts with the double-layered membrane of the cell nucleus (known as the nuclear envelope), leading to significant damage to cells along with virus replication and the propagation of disease.
Mount Sinai Welcomes Robotic Prostate Surgery Pioneer Mani Menon, MD
Robotic prostate surgery pioneer Mani Menon, MD, is joining Mount Sinai and will serve as Chief of Strategy and Innovation in the Department of Urology for the Mount Sinai Health System. He will also serve as a Professor of Urology, Director of Education and Director of the Precision Prostatectomy Program in the Department of Urology at Icahn Mount Sinai and Center of Excellence for Prostate Cancer at The Tisch Cancer Institute.
Mount Sinai Leaders Discuss Equity, the Impact of the Pandemic on Healthcare, and the Unprecedented Era and Increasing Interest of Psychedelics on Treating Mental Health at the 2021 Aspen Ideas Health and Aspen Ideas Festival
Reflections on the pandemic, developing innovative solutions to address inequities in health and medicine, and the use of psychedelic drugs to help treat psychiatric disorders are among the topics presented at Aspen Ideas Health and the Aspen Ideas Festival from June 27-July 1, 2021, in Aspen, Colorado. Presented by the Aspen Institute and sponsored by the Mount Sinai Health System, the festival is a unique forum for the exchange of ideas.
Mount Sinai Study Finds That Rotator Cuff Injuries Account for Nearly Half of Shoulder Injuries Among Collegiate Baseball Players, Identifies Other Risks
Repetitive overhead throwing is a risk factor for shoulder injuries in collegiate baseball players, often leading to rotator cuff and biceps tendon injuries.
Mount Sinai’s Simulation Teaching and Research Center Earns Four Accreditations From Society for Simulation in Healthcare
Only center in the world with this combination of distinctions
Ali N. Zaidi, MD, to Receive Prestigious Honor From American Heart Association on Long Island
Cardiologist will partner with organization to create awareness for congenital heart disease to improve community health
“We Find a Way”: Mount Sinai Launches National Brand and Advertising Campaign
Campaign showcases the people and innovators who are relentlessly advancing medicine and health
The Mount Sinai Hospital Recognized as No. 4 on Newsweek’s World’s Best Smart Hospital 2021 List
The Mount Sinai Hospital is ranked No. 1 in the New York City metropolitan area and No. 4 globally among the most technologically advanced health care institutions on Newsweek’s list of “The World’s Best Smart Hospitals 2021.”
Mount Sinai Health System Launches Elementa Labs, A Virtual Incubator Program
Elementa Labs will connect health care startup companies with Mount Sinai’s vast network of research and clinical experts to advance groundbreaking health care innovations.
High Caffeine Consumption may be Associated with Increased Risk of Blinding Eye Disease
Frequent caffeine intake could more than triple risk of glaucoma for those genetically predisposed to higher eye pressure
Mount Sinai identifies the causes of racial disparity in prostate cancer in a multi-institutional study
MEDIA ADVISORY Senior Author: Ash Tewari, MBBS, MCh, Professor and System Chairman of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai and Director of the Center of Excellence for Prostate Cancer…
A Technique for Regulating Emotion May be Effective in Disrupting Compulsive Cocaine Addiction, a Mount Sinai Study Has Found
An emotion regulation strategy known as cognitive reappraisal helped reduce the typically heightened and habitual attention to drug-related cues and contexts in cocaine-addicted individuals, a study by Mount Sinai researchers has found.
Mount Sinai Health System and Pershing Square Foundation Announce Expansion of New Saliva-Based COVID-19 Testing Program
Expanded program will be available to NYC schools and other organizations
Fat Around the Heart Linked to Increased Risk of Heart Failure
EMBARGOED UNTIL MAY 24 2:00PM EST (New York, NY – May 24, 2021) – Having excess pericardial fat—fat around the heart—increases the risk of developing heart failure, especially in women, according to new Mount Sinai research. Women with high amounts…
Oral Medication Shows Strong Promise for Moderate to Severe Atopic Dermatitis in Mount Sinai-led Study
An oral medication called upadacitinib yielded rapid and significant improvements in patients with moderate to severe atopic dermatitis (AD), also known as eczema, in phase 3 clinical trials, Mount Sinai researchers reported today in The Lancet online.
Mount Sinai Cardiovascular Doctors to Receive Honors During American College of Cardiology 70th Annual Scientific Session
William Whang, MD, Associate Professor of Medicine (Cardiology), and Gilbert Tang, MD, MSc, MBA, Associate Professor of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai, are receiving the 2021 Simon Dack Awards for their exceptional contributions to the Journal of the American College of Cardiology (JACC).
Comprehensive Mount Sinai Study Shows Direct Evidence That COVID-19 Can Infect Cells in Eye
Study Has Implications for Preventive Measures to Slow Spread of Virus
Study Shows Significant Reduction in Triglycerides in Patients at High Risk for Acute Pancreatitis Through Novel Monoclonal Antibody
The investigational drug evinacumab reduced triglycerides in patients with severe hypertriglyceridemia (sHTG) and a history of hospitalizations for acute pancreatitis in a phase 2 global study led by Mount Sinai
Biopreparedness Expert Gustavo Palacios, PhD, to Join Mount Sinai, Strengthening Research Collaborations with Department of Defense
Virologist Gustavo Palacios, PhD, is joining the Icahn School of Medicine at Mount Sinai from the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), where he led the application and development of molecular epidemiology to advance the field of biopreparedness. Dr. Palacios will strengthen existing research collaborations between Icahn Mount Sinai and the United States Army-Department of Defense (DoD), laying a foundation for joint research initiatives to protect national and global public health.
Mount Sinai Department of Surgery Launches Program to Combat Burnout and Manage Stress Among Surgical Faculty, Trainees & Staff
Recognizing that burnout and stress have a negative impact on the personal and professional lives of faculty, staff, and trainees, as well as the quality of care that patients receive, the Mount Sinai Department of Surgery has launched the Stress Intervention Tools (SIT) program to help surgeons work through their emotions, reduce their anxiety, and manage crises.
Oula Announces Hospital Partnership with Mount Sinai West for Deliveries
Oula, a modern maternity center combining the best of obstetrics and midwifery care, today announced its partnership with Mount Sinai West, one of New York’s well-respected hospitals, located on the west side of Manhattan. Through this partnership, Oula patients — who receive prenatal, birth, and postpartum care via the company’s collaborative medical team, Brooklyn clinic, and remote care platform — will now be able to deliver their babies at Mount Sinai. They will receive full access to hospital resources and specialists they may need, all while remaining under the care of Oula’s medical team for non-surgical births.
Hepatitis C Drugs Combined with Remdesivir Show Strong Effectiveness Against COVID-19
A combination of remdesivir, a drug currently approved in the United States for treating COVID-19 patients, and repurposed drugs for hepatitis C virus (HCV) was 10 times more effective at inhibiting SARS-CoV-2, the virus that causes COVID-19.
Mount Sinai Study Finds That Blood Clotting Drug Commonly Used for Orthopedic Surgeries Does Not Increase Complications for High-Risk Patients
Mount Sinai Researchers Find That Tranexamic Acid, a Blood Clotting Drug Commonly Used for Orthopedic Surgeries, Does Not Increase Complications for High-Risk Patients
Genetic Ancestry Versus Race Can Provide Specific, Targeted Insights to Predict and Treat Many Diseases
The complex patterns of genetic ancestry uncovered from genomic data in health care systems can provide valuable insights into both genetic and environmental factors underlying many common and rare diseases, according to a team of Mount Sinai researchers.